APO Research

APO RESEARCH · REPORT

Pet Genetic Defect Screening Platform

Selected research

Market Structure

Global Pet Genetic Defect Screening Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Pet Genetic Defect Screening Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Pet Genetic Defect Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Genetic Defect Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Genetic Defect Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Genetic Defect Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Genetic Defect Screening Platform include Wisdom Panel, Embark Veterinary, Basepaws, Orivet Genetic Pet Care, Paw Print Genetics, Animal Genetics, VetGen, Antagene and Laboklin, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Pet Genetic Defect Screening Platform market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Genetic Defect Screening Platform and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Genetic Defect Screening Platform revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Pet Genetic Defect Screening Platform market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Genetic Defect Screening Platform Segment by Company

Wisdom Panel

Embark Veterinary

Basepaws

Orivet Genetic Pet Care

Paw Print Genetics

Animal Genetics

VetGen

Antagene

Laboklin

UC Davis

OptiGen

VHLGenetics

Sinogene

PawKnows

Circle Dog

BGI Genomics

GENEWIZ

Pet Genetic Defect Screening Platform Segment by Type

Single Disease Gene Screening Platform

Whole Genome Multi-Disease Comprehensive Screening Platform

Pet Genetic Defect Screening Platform Segment by Application

Medical Institutions

Insurance Companies

Pet Breeding Companies

Others

Pet Genetic Defect Screening Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Genetic Defect Screening Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Genetic Defect Screening Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Genetic Defect Screening Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Pet Genetic Defect Screening Platform in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Genetic Defect Screening Platform industry.

Chapter 3: Detailed analysis of Pet Genetic Defect Screening Platform companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Genetic Defect Screening Platformrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Single Disease Gene Screening Platform Table 3. Key Players of Whole Genome Multi-Disease Comprehensive Screening Platform Table 4. Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medical Institutions Table 6. Key Players of Insurance Companies Table 7. Key Players of Pet Breeding Companies Table 8. Key Players of Others Table 9. Global Pet Genetic Defect Screening Platform Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Pet Genetic Defect Screening Platform Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Pet Genetic Defect Screening Platform Market Share by Region (2021-2026) Table 12. Global Pet Genetic Defect Screening Platform Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Pet Genetic Defect Screening Platform Market Share by Region (2027-2032) Table 14. Pet Genetic Defect Screening Platform Industry Trends Table 15. Pet Genetic Defect Screening Platform Industry Drivers Table 16. Pet Genetic Defect Screening Platform Industry Opportunities and Challenges Table 17. Pet Genetic Defect Screening Platform Industry Restraints Table 18. Global Pet Genetic Defect Screening Platform Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Pet Genetic Defect Screening Platform Revenue Market Share by Company (2021-2026) Table 20. Global Pet Genetic Defect Screening Platform Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Pet Genetic Defect Screening Platform Key Company Head Office and Area Served Table 22. Global Pet Genetic Defect Screening Platform Company, Product Type & Application Table 23. Global Pet Genetic Defect Screening Platform Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Pet Genetic Defect Screening Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Pet Genetic Defect Screening Platform Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Pet Genetic Defect Screening Platform Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Pet Genetic Defect Screening Platform Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Pet Genetic Defect Screening Platform Revenue Market Share by Type (2021-2026) Table 30. Global Pet Genetic Defect Screening Platform Revenue Market Share by Type (2027-2032) Table 31. Global Pet Genetic Defect Screening Platform Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Pet Genetic Defect Screening Platform Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Pet Genetic Defect Screening Platform Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Pet Genetic Defect Screening Platform Revenue Market Share by Application (2021-2026) Table 35. Global Pet Genetic Defect Screening Platform Revenue Market Share by Application (2027-2032) Table 36. Wisdom Panel Company Information Table 37. Wisdom Panel Business Overview Table 38. Wisdom Panel Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Wisdom Panel Pet Genetic Defect Screening Platform Product Portfolio Table 40. Wisdom Panel Recent Development Table 41. Embark Veterinary Company Information Table 42. Embark Veterinary Business Overview Table 43. Embark Veterinary Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Embark Veterinary Pet Genetic Defect Screening Platform Product Portfolio Table 45. Embark Veterinary Recent Development Table 46. Basepaws Company Information Table 47. Basepaws Business Overview Table 48. Basepaws Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Basepaws Pet Genetic Defect Screening Platform Product Portfolio Table 50. Basepaws Recent Development Table 51. Orivet Genetic Pet Care Company Information Table 52. Orivet Genetic Pet Care Business Overview Table 53. Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Product Portfolio Table 55. Orivet Genetic Pet Care Recent Development Table 56. Paw Print Genetics Company Information Table 57. Paw Print Genetics Business Overview Table 58. Paw Print Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Paw Print Genetics Pet Genetic Defect Screening Platform Product Portfolio Table 60. Paw Print Genetics Recent Development Table 61. Animal Genetics Company Information Table 62. Animal Genetics Business Overview Table 63. Animal Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Animal Genetics Pet Genetic Defect Screening Platform Product Portfolio Table 65. Animal Genetics Recent Development Table 66. VetGen Company Information Table 67. VetGen Business Overview Table 68. VetGen Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. VetGen Pet Genetic Defect Screening Platform Product Portfolio Table 70. VetGen Recent Development Table 71. Antagene Company Information Table 72. Antagene Business Overview Table 73. Antagene Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Antagene Pet Genetic Defect Screening Platform Product Portfolio Table 75. Antagene Recent Development Table 76. Laboklin Company Information Table 77. Laboklin Business Overview Table 78. Laboklin Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Laboklin Pet Genetic Defect Screening Platform Product Portfolio Table 80. Laboklin Recent Development Table 81. UC Davis Company Information Table 82. UC Davis Business Overview Table 83. UC Davis Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. UC Davis Pet Genetic Defect Screening Platform Product Portfolio Table 85. UC Davis Recent Development Table 86. OptiGen Company Information Table 87. OptiGen Business Overview Table 88. OptiGen Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. OptiGen Pet Genetic Defect Screening Platform Product Portfolio Table 90. OptiGen Recent Development Table 91. VHLGenetics Company Information Table 92. VHLGenetics Business Overview Table 93. VHLGenetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. VHLGenetics Pet Genetic Defect Screening Platform Product Portfolio Table 95. VHLGenetics Recent Development Table 96. Sinogene Company Information Table 97. Sinogene Business Overview Table 98. Sinogene Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Sinogene Pet Genetic Defect Screening Platform Product Portfolio Table 100. Sinogene Recent Development Table 101. PawKnows Company Information Table 102. PawKnows Business Overview Table 103. PawKnows Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. PawKnows Pet Genetic Defect Screening Platform Product Portfolio Table 105. PawKnows Recent Development Table 106. Circle Dog Company Information Table 107. Circle Dog Business Overview Table 108. Circle Dog Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Circle Dog Pet Genetic Defect Screening Platform Product Portfolio Table 110. Circle Dog Recent Development Table 111. BGI Genomics Company Information Table 112. BGI Genomics Business Overview Table 113. BGI Genomics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. BGI Genomics Pet Genetic Defect Screening Platform Product Portfolio Table 115. BGI Genomics Recent Development Table 116. GENEWIZ Company Information Table 117. GENEWIZ Business Overview Table 118. GENEWIZ Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. GENEWIZ Pet Genetic Defect Screening Platform Product Portfolio Table 120. GENEWIZ Recent Development Table 121. North America Pet Genetic Defect Screening Platform Market Size by Type (2021-2026) & (US$ Million) Table 122. North America Pet Genetic Defect Screening Platform Market Size by Type (2027-2032) & (US$ Million) Table 123. North America Pet Genetic Defect Screening Platform Market Size by Application (2021-2026) & (US$ Million) Table 124. North America Pet Genetic Defect Screening Platform Market Size by Application (2027-2032) & (US$ Million) Table 125. North America Pet Genetic Defect Screening Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Pet Genetic Defect Screening Platform Market Size by Country (2021-2026) Table 127. North America Pet Genetic Defect Screening Platform Market Size by Country (2027-2032) Table 128. Europe Pet Genetic Defect Screening Platform Market Size by Type (2021-2026) & (US$ Million) Table 129. Europe Pet Genetic Defect Screening Platform Market Size by Type (2027-2032) & (US$ Million) Table 130. Europe Pet Genetic Defect Screening Platform Market Size by Application (2021-2026) & (US$ Million) Table 131. Europe Pet Genetic Defect Screening Platform Market Size by Application (2027-2032) & (US$ Million) Table 132. Europe Pet Genetic Defect Screening Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Pet Genetic Defect Screening Platform Market Size by Country (2021-2026) Table 134. Europe Pet Genetic Defect Screening Platform Market Size by Country (2027-2032) Table 135. China Pet Genetic Defect Screening Platform Market Size by Type (2021-2026) & (US$ Million) Table 136. China Pet Genetic Defect Screening Platform Market Size by Type (2027-2032) & (US$ Million) Table 137. China Pet Genetic Defect Screening Platform Market Size by Application (2021-2026) & (US$ Million) Table 138. China Pet Genetic Defect Screening Platform Market Size by Application (2027-2032) & (US$ Million) Table 139. Asia Pet Genetic Defect Screening Platform Market Size by Type (2021-2026) & (US$ Million) Table 140. Asia Pet Genetic Defect Screening Platform Market Size by Type (2027-2032) & (US$ Million) Table 141. Asia Pet Genetic Defect Screening Platform Market Size by Application (2021-2026) & (US$ Million) Table 142. Asia Pet Genetic Defect Screening Platform Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Pet Genetic Defect Screening Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Pet Genetic Defect Screening Platform Market Size by Country (2021-2026) Table 145. Asia Pet Genetic Defect Screening Platform Market Size by Country (2027-2032) Table 146. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Type (2021-2026) & (US$ Million) Table 147. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Type (2027-2032) & (US$ Million) Table 148. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Application (2021-2026) & (US$ Million) Table 149. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Application (2027-2032) & (US$ Million) Table 150. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Country (2021-2026) Table 152. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Pet Genetic Defect Screening Platform Product Image Figure 2. Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Pet Genetic Defect Screening Platform Market Share by Type: 2025 VS 2032 Figure 4. Single Disease Gene Screening Platform Image Figure 5. Whole Genome Multi-Disease Comprehensive Screening Platform Image Figure 6. Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Pet Genetic Defect Screening Platform Market Share by Application: 2025 VS 2032 Figure 8. Medical Institutions Image Figure 9. Insurance Companies Image Figure 10. Pet Breeding Companies Image Figure 11. Others Image Figure 12. Global Pet Genetic Defect Screening Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 14. Global Pet Genetic Defect Screening Platform Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Pet Genetic Defect Screening Platform Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Pet Genetic Defect Screening Platform Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Pet Genetic Defect Screening Platform Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pet Genetic Defect Screening Platform Revenue Market Share by Type (2021-2032) Figure 21. Global Pet Genetic Defect Screening Platform Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Pet Genetic Defect Screening Platform Revenue Market Share by Application (2021-2032) Figure 23. North America Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 24. North America Pet Genetic Defect Screening Platform Market Share by Type (2021-2032) Figure 25. North America Pet Genetic Defect Screening Platform Market Share by Application (2021-2032) Figure 26. North America Pet Genetic Defect Screening Platform Market Share by Country (2021-2032) Figure 27. United States Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 28. Canada Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 30. Europe Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 31. Europe Pet Genetic Defect Screening Platform Market Share by Type (2021-2032) Figure 32. Europe Pet Genetic Defect Screening Platform Market Share by Application (2021-2032) Figure 33. Europe Pet Genetic Defect Screening Platform Market Share by Country (2021-2032) Figure 34. Germany Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 35. France Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 37. Italy Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 38. Russia Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 40. China Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 41. China Pet Genetic Defect Screening Platform Market Share by Type (2021-2032) Figure 42. China Pet Genetic Defect Screening Platform Market Share by Application (2021-2032) Figure 43. Asia Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 44. Asia Pet Genetic Defect Screening Platform Market Share by Type (2021-2032) Figure 45. Asia Pet Genetic Defect Screening Platform Market Share by Application (2021-2032) Figure 46. Asia Pet Genetic Defect Screening Platform Market Share by Country (2021-2032) Figure 47. Japan Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 51. India Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 52. Australia Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Share by Country (2021-2032) Figure 57. Brazil Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 62. UAE Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 64. Chile Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Single Disease Gene Screening Platform
  • Whole Genome Multi-Disease Comprehensive Screening Platform
Applications
  • Medical Institutions
  • Insurance Companies
  • Pet Breeding Companies
  • Others
Companies covered
  • Wisdom Panel
  • Embark Veterinary
  • Basepaws
  • Orivet Genetic Pet Care
  • Paw Print Genetics
  • Animal Genetics
  • VetGen
  • Antagene
  • Laboklin
  • UC Davis
  • OptiGen
  • VHLGenetics
  • Sinogene
  • PawKnows
  • Circle Dog
  • BGI Genomics
  • GENEWIZ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Single Disease Gene Screening Platform
  5. 1.2.3 Whole Genome Multi-Disease Comprehensive Screening Platform
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Pet Genetic Defect Screening Platform Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Institutions
  9. 1.3.3 Insurance Companies
  10. 1.3.4 Pet Breeding Companies
  11. 1.3.5 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Pet Genetic Defect Screening Platform Growth Trends by Region
  14. 1.5.1 Global Pet Genetic Defect Screening Platform Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Pet Genetic Defect Screening Platform Market Size by Region (2021-2026)
  16. 1.5.3 Pet Genetic Defect Screening Platform Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Pet Genetic Defect Screening Platform Market Dynamics
  1. 2.1 Pet Genetic Defect Screening Platform Industry Trends
  2. 2.2 Pet Genetic Defect Screening Platform Industry Drivers
  3. 2.3 Pet Genetic Defect Screening Platform Industry Opportunities and Challenges
  4. 2.4 Pet Genetic Defect Screening Platform Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Pet Genetic Defect Screening Platform Revenue by Company (2021-2026)
  2. 3.2 Global Pet Genetic Defect Screening Platform Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Pet Genetic Defect Screening Platform Key Company Head office and Area Served
  4. 3.4 Global Pet Genetic Defect Screening Platform Company, Product Type & Application
  5. 3.5 Global Pet Genetic Defect Screening Platform Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Pet Genetic Defect Screening Platform Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Pet Genetic Defect Screening Platform Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Pet Genetic Defect Screening Platform Tier 1, Tier 2, and Tier 3
4 Pet Genetic Defect Screening Platform Market by Type
  1. 4.1 Global Pet Genetic Defect Screening Platform Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Pet Genetic Defect Screening Platform Market Size by Type (2021-2032)
  3. 4.3 Global Pet Genetic Defect Screening Platform Market Size Share by Type (2021-2032)
5 Pet Genetic Defect Screening Platform Market by Application
  1. 5.1 Global Pet Genetic Defect Screening Platform Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Pet Genetic Defect Screening Platform Market Size by Application (2021-2032)
  3. 5.3 Global Pet Genetic Defect Screening Platform Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Wisdom Panel
  2. 6.1.1 Wisdom Panel Company Information
  3. 6.1.2 Wisdom Panel Business Overview
  4. 6.1.3 Wisdom Panel Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Wisdom Panel Pet Genetic Defect Screening Platform Product Portfolio
  6. 6.1.5 Wisdom Panel Recent Developments
  7. 6.2 Embark Veterinary
  8. 6.2.1 Embark Veterinary Company Information
  9. 6.2.2 Embark Veterinary Business Overview
  10. 6.2.3 Embark Veterinary Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Embark Veterinary Pet Genetic Defect Screening Platform Product Portfolio
  12. 6.2.5 Embark Veterinary Recent Developments
  13. 6.3 Basepaws
  14. 6.3.1 Basepaws Company Information
  15. 6.3.2 Basepaws Business Overview
  16. 6.3.3 Basepaws Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Basepaws Pet Genetic Defect Screening Platform Product Portfolio
  18. 6.3.5 Basepaws Recent Developments
  19. 6.4 Orivet Genetic Pet Care
  20. 6.4.1 Orivet Genetic Pet Care Company Information
  21. 6.4.2 Orivet Genetic Pet Care Business Overview
  22. 6.4.3 Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Product Portfolio
  24. 6.4.5 Orivet Genetic Pet Care Recent Developments
  25. 6.5 Paw Print Genetics
  26. 6.5.1 Paw Print Genetics Company Information
  27. 6.5.2 Paw Print Genetics Business Overview
  28. 6.5.3 Paw Print Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Paw Print Genetics Pet Genetic Defect Screening Platform Product Portfolio
  30. 6.5.5 Paw Print Genetics Recent Developments
  31. 6.6 Animal Genetics
  32. 6.6.1 Animal Genetics Company Information
  33. 6.6.2 Animal Genetics Business Overview
  34. 6.6.3 Animal Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Animal Genetics Pet Genetic Defect Screening Platform Product Portfolio
  36. 6.6.5 Animal Genetics Recent Developments
  37. 6.7 VetGen
  38. 6.7.1 VetGen Company Information
  39. 6.7.2 VetGen Business Overview
  40. 6.7.3 VetGen Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 VetGen Pet Genetic Defect Screening Platform Product Portfolio
  42. 6.7.5 VetGen Recent Developments
  43. 6.8 Antagene
  44. 6.8.1 Antagene Company Information
  45. 6.8.2 Antagene Business Overview
  46. 6.8.3 Antagene Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Antagene Pet Genetic Defect Screening Platform Product Portfolio
  48. 6.8.5 Antagene Recent Developments
  49. 6.9 Laboklin
  50. 6.9.1 Laboklin Company Information
  51. 6.9.2 Laboklin Business Overview
  52. 6.9.3 Laboklin Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Laboklin Pet Genetic Defect Screening Platform Product Portfolio
  54. 6.9.5 Laboklin Recent Developments
  55. 6.10 UC Davis
  56. 6.10.1 UC Davis Company Information
  57. 6.10.2 UC Davis Business Overview
  58. 6.10.3 UC Davis Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 UC Davis Pet Genetic Defect Screening Platform Product Portfolio
  60. 6.10.5 UC Davis Recent Developments
  61. 6.11 OptiGen
  62. 6.11.1 OptiGen Company Information
  63. 6.11.2 OptiGen Business Overview
  64. 6.11.3 OptiGen Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 OptiGen Pet Genetic Defect Screening Platform Product Portfolio
  66. 6.11.5 OptiGen Recent Developments
  67. 6.12 VHLGenetics
  68. 6.12.1 VHLGenetics Company Information
  69. 6.12.2 VHLGenetics Business Overview
  70. 6.12.3 VHLGenetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 VHLGenetics Pet Genetic Defect Screening Platform Product Portfolio
  72. 6.12.5 VHLGenetics Recent Developments
  73. 6.13 Sinogene
  74. 6.13.1 Sinogene Company Information
  75. 6.13.2 Sinogene Business Overview
  76. 6.13.3 Sinogene Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Sinogene Pet Genetic Defect Screening Platform Product Portfolio
  78. 6.13.5 Sinogene Recent Developments
  79. 6.14 PawKnows
  80. 6.14.1 PawKnows Company Information
  81. 6.14.2 PawKnows Business Overview
  82. 6.14.3 PawKnows Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 PawKnows Pet Genetic Defect Screening Platform Product Portfolio
  84. 6.14.5 PawKnows Recent Developments
  85. 6.15 Circle Dog
  86. 6.15.1 Circle Dog Company Information
  87. 6.15.2 Circle Dog Business Overview
  88. 6.15.3 Circle Dog Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Circle Dog Pet Genetic Defect Screening Platform Product Portfolio
  90. 6.15.5 Circle Dog Recent Developments
  91. 6.16 BGI Genomics
  92. 6.16.1 BGI Genomics Company Information
  93. 6.16.2 BGI Genomics Business Overview
  94. 6.16.3 BGI Genomics Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 BGI Genomics Pet Genetic Defect Screening Platform Product Portfolio
  96. 6.16.5 BGI Genomics Recent Developments
  97. 6.17 GENEWIZ
  98. 6.17.1 GENEWIZ Company Information
  99. 6.17.2 GENEWIZ Business Overview
  100. 6.17.3 GENEWIZ Pet Genetic Defect Screening Platform Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 GENEWIZ Pet Genetic Defect Screening Platform Product Portfolio
  102. 6.17.5 GENEWIZ Recent Developments
7 North America
  1. 7.1 North America Pet Genetic Defect Screening Platform Market Size (2021-2032)
  2. 7.2 North America Pet Genetic Defect Screening Platform Market Size by Type
  3. 7.2.1 North America Pet Genetic Defect Screening Platform Market Size by Type (2021-2026)
  4. 7.2.2 North America Pet Genetic Defect Screening Platform Market Size by Type (2027-2032)
  5. 7.2.3 North America Pet Genetic Defect Screening Platform Market Share by Type (2021-2032)
  6. 7.3 North America Pet Genetic Defect Screening Platform Market Size by Application
  7. 7.3.1 North America Pet Genetic Defect Screening Platform Market Size by Application (2021-2026)
  8. 7.3.2 North America Pet Genetic Defect Screening Platform Market Size by Application (2027-2032)
  9. 7.3.3 North America Pet Genetic Defect Screening Platform Market Share by Application (2021-2032)
  10. 7.4 North America Pet Genetic Defect Screening Platform Market Size by Country
  11. 7.4.1 North America Pet Genetic Defect Screening Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Pet Genetic Defect Screening Platform Market Size by Country (2021-2026)
  13. 7.4.3 North America Pet Genetic Defect Screening Platform Market Size by Country (2027-2032)
  14. 7.4.4 North America Pet Genetic Defect Screening Platform Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Pet Genetic Defect Screening Platform Market Size (2021-2032)
  2. 8.2 Europe Pet Genetic Defect Screening Platform Market Size by Type
  3. 8.2.1 Europe Pet Genetic Defect Screening Platform Market Size by Type (2021-2026)
  4. 8.2.2 Europe Pet Genetic Defect Screening Platform Market Size by Type (2027-2032)
  5. 8.2.3 Europe Pet Genetic Defect Screening Platform Market Share by Type (2021-2032)
  6. 8.3 Europe Pet Genetic Defect Screening Platform Market Size by Application
  7. 8.3.1 Europe Pet Genetic Defect Screening Platform Market Size by Application (2021-2026)
  8. 8.3.2 Europe Pet Genetic Defect Screening Platform Market Size by Application (2027-2032)
  9. 8.3.3 Europe Pet Genetic Defect Screening Platform Market Share by Application (2021-2032)
  10. 8.4 Europe Pet Genetic Defect Screening Platform Market Size by Country
  11. 8.4.1 Europe Pet Genetic Defect Screening Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Pet Genetic Defect Screening Platform Market Size by Country (2021-2026)
  13. 8.4.3 Europe Pet Genetic Defect Screening Platform Market Size by Country (2027-2032)
  14. 8.4.4 Europe Pet Genetic Defect Screening Platform Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Pet Genetic Defect Screening Platform Market Size (2021-2032)
  2. 9.2 China Pet Genetic Defect Screening Platform Market Size by Type
  3. 9.2.1 China Pet Genetic Defect Screening Platform Market Size by Type (2021-2026)
  4. 9.2.2 China Pet Genetic Defect Screening Platform Market Size by Type (2027-2032)
  5. 9.2.3 China Pet Genetic Defect Screening Platform Market Share by Type (2021-2032)
  6. 9.3 China Pet Genetic Defect Screening Platform Market Size by Application
  7. 9.3.1 China Pet Genetic Defect Screening Platform Market Size by Application (2021-2026)
  8. 9.3.2 China Pet Genetic Defect Screening Platform Market Size by Application (2027-2032)
  9. 9.3.3 China Pet Genetic Defect Screening Platform Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Pet Genetic Defect Screening Platform Market Size (2021-2032)
  2. 10.2 Asia Pet Genetic Defect Screening Platform Market Size by Type
  3. 10.2.1 Asia Pet Genetic Defect Screening Platform Market Size by Type (2021-2026)
  4. 10.2.2 Asia Pet Genetic Defect Screening Platform Market Size by Type (2027-2032)
  5. 10.2.3 Asia Pet Genetic Defect Screening Platform Market Share by Type (2021-2032)
  6. 10.3 Asia Pet Genetic Defect Screening Platform Market Size by Application
  7. 10.3.1 Asia Pet Genetic Defect Screening Platform Market Size by Application (2021-2026)
  8. 10.3.2 Asia Pet Genetic Defect Screening Platform Market Size by Application (2027-2032)
  9. 10.3.3 Asia Pet Genetic Defect Screening Platform Market Share by Application (2021-2032)
  10. 10.4 Asia Pet Genetic Defect Screening Platform Market Size by Country
  11. 10.4.1 Asia Pet Genetic Defect Screening Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Pet Genetic Defect Screening Platform Market Size by Country (2021-2026)
  13. 10.4.3 Asia Pet Genetic Defect Screening Platform Market Size by Country (2027-2032)
  14. 10.4.4 Asia Pet Genetic Defect Screening Platform Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Pet Genetic Defect Screening Platform Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research